Goldman Sachs Bonus Zert FRE 26.0.../ DE000GP1ENP5 /
30/05/2024 11:06:40 | Chg.- | Bid22:00:37 | Ask22:00:37 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
24.51EUR | - | - Bid Size: - |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | 20.00 - | 26/06/2024 | Put |
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
25/02/2022
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire
05/01/2022
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire
31/12/2021
CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire
09/12/2021
Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire
22/11/2021
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
22/11/2021
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
12/11/2021
Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights
GlobeNewswire
27/10/2021
CIO Leadership: Exemplifying Authentic Leadership and Leveraging Personal Branding to Act as a Globa...
GlobeNewswire
26/10/2021
Angion and Vifor Pharma Report Topline Results from Phase 3 Trial of ANG-3777 in Kidney Transplant P...
GlobeNewswire
15/09/2021
Travere Therapeutics and Vifor Pharma Announce Licensing Agreement for the Commercialization of Spar...